Episode 53: Christian Angermayer - Founder of Apeiron Investment Group

2026-05-11 · 5 company · 3 thematic

sentiment

4 bull0 bear1 neu

speakers

christian angermayer

German serial entrepreneur and investor who co-founded Alnylam Pharmaceuticals at age 20, founded Atai Life Sciences to bring psychedelic medicines to psychiatry, co-founded Compass Pathways, and launched Enhanced Games as a performance-enhancing drug-permitted sports league. Runs family office Apeiron Investment Group.

quote

“Now, it's called RNAi. Um and they talked about it. And I also want to admit like I understood only vaguely where they want to go, but I had a good feeling for Oh, wow, I think I know what you want to do, guys. And if this is going well, i…”

—christian angermayer

now playing · $ALNY

$ALNY···bullish· high· poschristian angermayer

Angermayer co-founded Alnylam on RNAi thesis, took public via SPAC at 25

RNAi technology could switch off genetic disease expression at the root cause, addressing a multi-billion dollar market with no existing treatments for genetic diseases.

$ATAI···bullish· high· poschristian angermayer

Angermayer's main holding Atai brings psychedelic medicines to mainstream psychiatry

Psychedelic compounds have near-zero downside when used medically with clinicians and can cure mental health issues; Atai is building the full suite of psychedelic medicines with…

$APEIRON-INVESTMENT-GROUPneutral· high· poschristian angermayer

Angermayer's family office Apeiron invests across lifecycle, seeds funds, and builds companies

Apeiron manages Angermayer's capital plus outside money, doing direct investments from seed to public equities, investing in third-party funds for diversification, and incubating…

$ENH···bullish· high· poschristian angermayer

Angermayer backs Enhanced Games: medical PEDs as recovery tools for athletes

FDA-approved performance-enhancing drugs under medical supervision help athletes recover from sport-induced bodily damage; Enhanced Games runs clinical trials to prove safety and…

$CMPS···bullish· high· poschristian angermayer

Angermayer seeded Compass Pathways, invested $1.5B proving psilocybin efficacy

Psilocybin can treat mental health with low doses; Compass proved the 1960s science works in modern trials, de-risking the entire psychedelic medicine category.